NEW YORK , Jan. 06, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc ., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that Dr. Sean Ianchulev, Chief Executive Officer and Chief Medical Officer, will